JAZZ Stock Ownership Activity

JAZZ PHARMACEUTICALS PLC 13F holders

No value investing guru has made any change to the JAZZ PHARMACEUTICALS PLC (JAZZ) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying JAZZ now?

According to the latest SEC filing(s) JAZZ PHARMACEUTICALS PLC (JAZZ) has not been purchased by any super investor.

To see more about who is investing in JAZZ PHARMACEUTICALS PLC (JAZZ), please go to the JAZZ ownership page.

2023 Q4 (1 result)
Seth Klarman
+23.75%
+160,000
+0.43%
2.24%
Current price: $108.99 11.39% Reported price*: $123.00
2023 Q2 (1 result)
Seth Klarman
+40.74%
+195,000
+0.44%
1.51%
Current price: $108.99 12.08% Reported price*: $123.97
2023 Q1 (1 result)
Seth Klarman
buy
+478,696
+1.20%
1.20%
Current price: $108.99 25.52% Reported price*: $146.33
2021 Q1 (1 result)
Ronald Muhlenkamp
-100.00%
-50,460
-3.08%
0.00%
Current price: $108.99 33.96% Reported price*: $165.04
2020 Q4 (1 result)
Ronald Muhlenkamp
+0.42%
+213
+0.01%
0.00%
Current price: $108.99 33.96% Reported price*: $165.04
2020 Q3 (1 result)
Ronald Muhlenkamp
+0.97%
+484
+0.04%
3.71%
Current price: $108.99 23.57% Reported price*: $142.60
2020 Q2 (1 result)
Ronald Muhlenkamp
+0.28%
+137
+0.01%
2.94%
Current price: $108.99 1.23% Reported price*: $110.34
2019 Q4 (1 result)
Ronald Muhlenkamp
+36.93%
+13,384
+0.87%
3.24%
Current price: $108.99 26.99% Reported price*: $149.28
2019 Q3 (1 result)
Ronald Muhlenkamp
+0.11%
+39
+0.00%
2.26%
Current price: $108.99 14.94% Reported price*: $128.14
2019 Q2 (2 results)
Ronald Muhlenkamp
-0.33%
-121
-0.01%
2.51%
Ole Andreas Halvorsen
-100.00%
-635,736
-0.41%
0.00%
Current price: $108.99 23.55% AVG reported price*: $142.56
2019 Q1 (2 results)
Ronald Muhlenkamp
-1.75%
-647
-0.04%
2.46%
Ole Andreas Halvorsen
-30.67%
-281,256
-0.23%
0.00%
Current price: $108.99 23.76% AVG reported price*: $142.96
2018 Q4 (1 result)
Ole Andreas Halvorsen
-3.50%
-33,289
-0.02%
0.65%
Current price: $108.99 12.08% Reported price*: $123.96
2018 Q3 (2 results)
Ronald Muhlenkamp
-0.50%
-184
-0.01%
2.67%
Ole Andreas Halvorsen
+1.50%
+14,086
+0.01%
0.88%
Current price: $108.99 35.18% AVG reported price*: $168.13
2018 Q2 (2 results)
Ronald Muhlenkamp
buy
+37,155
+2.46%
2.46%
Ole Andreas Halvorsen
+21.60%
+166,307
+0.16%
0.92%
Current price: $108.99 36.74% AVG reported price*: $172.30
2018 Q1 (1 result)
Ole Andreas Halvorsen
-14.58%
-131,449
-0.12%
0.70%
Current price: $108.99 27.82% Reported price*: $150.99
2017 Q4 (1 result)
Ole Andreas Halvorsen
-24.73%
-296,129
-0.25%
0.75%
Current price: $108.99 19.06% Reported price*: $134.65
2017 Q3 (1 result)
Ole Andreas Halvorsen
+20.60%
+204,565
+0.19%
1.13%
Current price: $108.99 25.48% Reported price*: $146.25
2017 Q2 (1 result)
Ole Andreas Halvorsen
+401.90%
+795,071
+0.83%
1.04%
Current price: $108.99 29.91% Reported price*: $155.50
2017 Q1 (1 result)
Ole Andreas Halvorsen
buy
+197,830
+0.13%
0.13%
Current price: $108.99 24.90% Reported price*: $145.13
2016 Q4 (1 result)
Ole Andreas Halvorsen
-100.00%
-737,623
-0.41%
0.00%
Current price: $108.99 10.28% Reported price*: $121.48
2016 Q3 (1 result)
Ole Andreas Halvorsen
+19.19%
+118,761
+0.06%
0.00%
Current price: $108.99 10.28% Reported price*: $121.48
2016 Q2 (1 result)
Ole Andreas Halvorsen
buy
+618,862
+0.37%
0.37%
Current price: $108.99 22.87% Reported price*: $141.31
2015 Q2 (1 result)
Stephen Mandel
-100.00%
-260,985
-0.20%
0.00%
Current price: $108.99 36.92% Reported price*: $172.79
2015 Q1 (1 result)
Stephen Mandel
-86.14%
-1,622,669
-1.20%
0.00%
Current price: $108.99 36.92% Reported price*: $172.79
2014 Q4 (1 result)
Stephen Mandel
+5.31%
+95,047
+0.07%
1.32%
Current price: $108.99 33.43% Reported price*: $163.73
2014 Q3 (1 result)
Stephen Mandel
-14.30%
-298,520
-0.19%
1.15%
Current price: $108.99 32.12% Reported price*: $160.56
2014 Q2 (1 result)
Stephen Mandel
-10.98%
-257,359
-0.16%
1.28%
Current price: $108.99 25.86% Reported price*: $147.01
2014 Q1 (1 result)
Stephen Mandel
buy
+2,344,486
+1.46%
1.46%
Current price: $108.99 21.41% Reported price*: $138.68
32 of 32

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.